Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5132338> ?p ?o }
Showing triples 1 to 85 of
85
with 100 triples per page.
- Q5132338 subject Q8330853.
- Q5132338 subject Q8343807.
- Q5132338 subject Q8376590.
- Q5132338 subject Q8918235.
- Q5132338 subject Q8919936.
- Q5132338 abstract "Clevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable.It was approved by the United States Food and Drug Administration on August 1, 2008.".
- Q5132338 atcPrefix "C08".
- Q5132338 atcSuffix "CA16".
- Q5132338 bioavailability "100.0".
- Q5132338 casNumber "166432-28-6".
- Q5132338 fdaUniiCode "19O2GP3B7Q".
- Q5132338 iupacName "O3-(butanoyloxymethyl) O5-methyl (4R)- 4-(2,3-dichlorophenyl)-2,6-dimethyl- 1,4-dihydropyridine-3,5-dicarboxylate".
- Q5132338 pubchem "193993".
- Q5132338 thumbnail Clevidipine_structure.svg?width=300.
- Q5132338 wikiPageExternalLink phoenix.zhtml?c=122204&p=irol-newsArticle&ID=1182776&highlight=.
- Q5132338 wikiPageExternalLink ClevidipinePI1.pdf.
- Q5132338 wikiPageWikiLink Q102769.
- Q5132338 wikiPageWikiLink Q1067560.
- Q5132338 wikiPageWikiLink Q1073121.
- Q5132338 wikiPageWikiLink Q1079120.
- Q5132338 wikiPageWikiLink Q1163287.
- Q5132338 wikiPageWikiLink Q12152.
- Q5132338 wikiPageWikiLink Q12202.
- Q5132338 wikiPageWikiLink Q1323002.
- Q5132338 wikiPageWikiLink Q132501.
- Q5132338 wikiPageWikiLink Q1406926.
- Q5132338 wikiPageWikiLink Q161249.
- Q5132338 wikiPageWikiLink Q162867.
- Q5132338 wikiPageWikiLink Q181754.
- Q5132338 wikiPageWikiLink Q186319.
- Q5132338 wikiPageWikiLink Q186915.
- Q5132338 wikiPageWikiLink Q1940733.
- Q5132338 wikiPageWikiLink Q204711.
- Q5132338 wikiPageWikiLink Q209583.
- Q5132338 wikiPageWikiLink Q235007.
- Q5132338 wikiPageWikiLink Q275419.
- Q5132338 wikiPageWikiLink Q30.
- Q5132338 wikiPageWikiLink Q30612.
- Q5132338 wikiPageWikiLink Q407693.
- Q5132338 wikiPageWikiLink Q41861.
- Q5132338 wikiPageWikiLink Q418750.
- Q5132338 wikiPageWikiLink Q420031.
- Q5132338 wikiPageWikiLink Q421700.
- Q5132338 wikiPageWikiLink Q456026.
- Q5132338 wikiPageWikiLink Q47270.
- Q5132338 wikiPageWikiLink Q5172195.
- Q5132338 wikiPageWikiLink Q531019.
- Q5132338 wikiPageWikiLink Q575278.
- Q5132338 wikiPageWikiLink Q575890.
- Q5132338 wikiPageWikiLink Q629460.
- Q5132338 wikiPageWikiLink Q640448.
- Q5132338 wikiPageWikiLink Q7180990.
- Q5132338 wikiPageWikiLink Q723758.
- Q5132338 wikiPageWikiLink Q7254644.
- Q5132338 wikiPageWikiLink Q72711.
- Q5132338 wikiPageWikiLink Q729213.
- Q5132338 wikiPageWikiLink Q7916469.
- Q5132338 wikiPageWikiLink Q816759.
- Q5132338 wikiPageWikiLink Q824258.
- Q5132338 wikiPageWikiLink Q82642.
- Q5132338 wikiPageWikiLink Q8330853.
- Q5132338 wikiPageWikiLink Q8343807.
- Q5132338 wikiPageWikiLink Q8376590.
- Q5132338 wikiPageWikiLink Q84133.
- Q5132338 wikiPageWikiLink Q844935.
- Q5132338 wikiPageWikiLink Q854573.
- Q5132338 wikiPageWikiLink Q8918235.
- Q5132338 wikiPageWikiLink Q8919936.
- Q5132338 wikiPageWikiLink Q9377.
- Q5132338 wikiPageWikiLink Q970208.
- Q5132338 atcPrefix "8.0".
- Q5132338 atcSuffix "CA16".
- Q5132338 bioavailability "100.0".
- Q5132338 casNumber "166432".
- Q5132338 iupacName "O3- O5-methyl - 4--2,6-dimethyl- 1,4-dihydropyridine-3,5-dicarboxylate".
- Q5132338 pubchem "193993".
- Q5132338 unii "19".
- Q5132338 type ChemicalSubstance.
- Q5132338 type Drug.
- Q5132338 type ChemicalObject.
- Q5132338 type Thing.
- Q5132338 type Q8386.
- Q5132338 comment "Clevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable.It was approved by the United States Food and Drug Administration on August 1, 2008.".
- Q5132338 label "Clevidipine".
- Q5132338 depiction Clevidipine_structure.svg.